| Issue Date | Title | Author(s) |
| 2014 | Cellular, molecular and functional characterisation of YAC transgenic mouse models of Friedreich Ataxia | Virmouni, SA; Sandi, C; Al-Mahdawi, S; Pook, MA |
| 2014 | Epigenetic-based therapies for Friedreich ataxia | Sandi, C; Sandi, M; Virmouni, SA; Al-Mahdawi, S; Pook, MA |
| 2013 | Epigenetics in Friedreich's ataxia: Challenges and opportunities for therapy | Sandi, C; Al-Mahdawi, S; Pook, MA |
| 2007 | The Friedreich ataxia GAA repeat expansion mutation induces comparable epigenetic changes in human and transgenic mouse brain and heart tissues | Pook, MA; Al-Mahdawi, S; Mouro Pinto, R; Sandi, C; Trabzuni, D |
| 2013 | Friedreich ataxia patient tissues exhibit increased 5-hydroxymethylcytosine modification and decreased CTCF binding at the FXN locus | Al-Mahdawi, S; Sandi, C; Mouro Pinto, R; Pook, MA |
| 2014 | Generation and characterisation of Friedreich ataxia YG8R mouse fibroblast and neural stem cell models | Sandi, C; Sandi, M; Jassal, H; Ezzatizadeh, V; Anjomani-Virmouni, S; Al-Mahdawi, S; Pook, MA |
| 2015 | Genotype and phenotype characterisation of enhanced Friedreich’s ataxia GAA repeat expansion mouse models | Anjomani Virmouni, S; Sandi, C; Ezzatizadeh, V; Sandi, M; Al-Mahdawi, S; Pook, M; Anjomani-Virmouni, S |
| 1-May-2015 | Identification of telomere dysfunction in Friedreich ataxia | Anjomani-Virmouni, S; Al-Mahdawi, S; Sandi, C; Yasaei, H; Slijepcevic, P; Pook, M |
| 10-Jun-2015 | Identification of telomere dysfunction in Friedreich ataxia. | Anjomani-Virmouni, S; Al-Mahdawi, S; Sandi, C; Yasaei, H; Giunti, P; Slijepcevic, P; Pook, M |
| 2012 | Interferon gamma upregulates frataxin and corrects the functional deficits in a Friedreich ataxia model | Tomassini, B; Arcuri, G; Fortuni, S; Sandi, C; Ezzatizadeh, V; Casali, C; Condò, I; Malisan, F; Al-Mahdawi, S; Pook, M; Testi, R |
| 2012 | The mismatch repair system protects against intergenerational GAA repeat instability in a Friedreich ataxia mouse model | Ezzatizadeh, V; Pinto, RM; Sandi, C; Sandi, M; Al-Mahdawi, S; Te Riele, H; Pook, MA |
| - | 'Mitochondrial energy imbalance and lipid peroxidation cause cell death in Friedreich's ataxia' | Parkinson, MH; Hargreaves, IP; Angelova, PR; Sandi, C; Pook, MA; Giunti, P; Abramov, AY |
| 2014 | MutLα heterodimers modify the molecular phenotype of Friedreich ataxia | Ezzatizadeh, V; Sandi, C; Sandi, M; Anjomani-Virmouni, S; Al-Mahdawi, S; Pook, MA |
| 2015 | A novel GAA-repeat-expansion-based mouse model of Friedreich's ataxia. | Anjomani Virmouni, S; Ezzatizadeh, V; Sandi, C; Sandi, M; Al-Mahdawi, S; Chutake, Y; Pook, MA |
| 2013 | Pharmacological screening using an FXN-EGFP cellular genomic reporter assay for the therapy of Friedreich ataxia | Li, L; Voullaire, L; Sandi, C; Pook, MA; Ioannou, PA; Delatycki, MB; Sarsero, JP |
| 2012 | Pms2 suppresses large expansions of the (GAA·TTC)n sequence in neuronal tissues | Bourn, RL; De Biase, I; Pinto, RM; Sandi, C; Al-Mahdawi, S; Pook, MA; Bidichandani, S |
| 2011 | Prolonged treatment with pimelic o-aminobenzamide HDAC inhibitors ameliorates the disease phenotype of a Friedreich ataxia mouse model | Sandi, C; Pinto, RM; Al-Mahdawi, S; Ezzatizadeh, V; Barnes, G; Jones, S; Rusche, JR; Gottesfeld, JM; Pook, MA |
